polycystic%20ovarian%20syndrome
POLYCYSTIC OVARIAN SYNDROME
Polycystic ovarian syndrome (PCOS) is the accumulation of underdeveloped follicles in the ovaries due to anovulation. It is is characterized by menstrual abnormalities and clinical or biochemical features of hyperandrogenism.
It results mainly from abnormal steroidogenesis that may be caused by insulin resistance leading to hyperinsulinemia.
There is increased sensitivity to androgens and the majority of women have elevated androgen levels.

Polycystic%20ovarian%20syndrome Diagnosis

Diagnosis

  • Diagnosis is based on 2003 Rotterdam criteria:
    • 2 out of 3 of the following: Oligo-ovulation or anovulation, clinical or biochemical signs of hyperandrogenism, polycystic ovaries
    • Exclusion of other causes (congenital adrenal hyperplasia, androgen-secreting tumors, Cushing’s syndrome, thyroid disease, prolactinoma)
  • Androgen Excess PCOS Society guidelines cite hyperandrogenism as an absolute requirement for diagnosis

History

  • Focus on the onset and duration of various signs of androgen excess, menstrual history and concomitant medications eg exogenous androgens
    • Menstrual history must screen for the status of ovulation in women with PCOS seeking fertility
  • Family history of DM or cardiovascular disease (CVD) (especially 1st-degree relatives with premature onset of CVD)

Physical Examination

  • Patients usually have features of hyperandrogenism and chronic anovulation; cutaneous symptoms of PCOS should be documented
    • Visual scales such as the modified Ferriman Gallwey score (mFG) for hirsutism and the Ludwig visual score for alopecia may be used during evaluation
  • Body mass index (BMI) and waist-hip ratio are calculated
  • Blood pressure

Laboratory Tests

  • Urine pregnancy test should be obtained in every patient in the reproductive age group reporting for menstrual abnormalities
  • If the patient presents with clinical features of hyperandrogenism with chronic anovulation, then other identifiable causes need to be excluded
  • Biochemical hyperandrogenism may be evaluated by measuring total or free testosterone or free androgen index using chromatography assays 
    • If total or free testosterone levels are not increased, consider measuring androstenedione and dehydroepiandrosterone (DHEAS), though additional information from these is limited
  • Patient should undergo lab tests to exclude:
    • Androgen-secreting tumors of the ovary or adrenal gland, late-onset congenital adrenal hyperplasia, and hyperprolactinemia
    • The above can be ruled out if prolactin, TSH, free testosterone, DHEAS and corticotropin-stimulated 17-α-hydroxyprogesterone levels are normal
  • Oral glucose tolerance test (OGTT) determines the degree of glucose tolerance and hyperinsulinemia 
  • Lipid profile
  • Midluteal serum progesterone may be done to document potential anovulation in PCOS patients with regular menses

Imaging

Ultrasonography

  • Used in the diagnosis of PCOS in patients who are 8 years past their menarche because a high incidence of multifollicular ovaries is seen in females with a gynecological age of <8 years 
  • Transvaginal ultrasound is the preferred approach if acceptable to the patient and if sexually active 
  • Determination of polycystic ovaries in one or both ovaries:
    • Endovaginal ultrasound findings of ≥20 follicles measuring 2-9 mm in diameter per ovary and/or increased ovarian volume (≥10 cm3) on either ovary; transabdominal ultrasound finding of an ovarian volume ≥10 cm3 due to difficulty of follicle counting
    • If there is a follicle >10 mm in diameter, the scan should be repeated at a time of ovarian quiescence in order to calculate volume and area
    • Presence of one polycystic ovary is sufficient to provide the diagnosis
  • Identification of endometrial abnormalities
    • Routine screening with ultrasound for endometrial thickness to rule out endometrial cancer in PCOS patients is not recommended
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
4 days ago
Daily intake of cow’s milk formula in early life helps prevent the development of cow’s milk allergy later on without competing with breastfeeding, a recent study has found.